Phenotype-based approaches provide an unbiased way to find active compounds in the context of complex biological systems. One of the major challenges is the need for target deconvolution and validation, i.e to be able to identify the molecular interactions that trigger a specific change in a phenotype.
We offer unbiased proteome-wide profiling using CETSA to provide key insights for phenotypic drug discovery in your disease-relevant system.
Get in touch
Contact us to learn more, to book a meeting or request a quote.